Clinical trial
Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
NCT06256211 is registered in ClinicalTrials.gov with Soha mahmoud Hussien mahdy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
- Lead sponsor
- Soha mahmoud Hussien mahdy
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- March 1, 2024
- Completion date
- December 30, 2024
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
patent ductus arteriosus